These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 7568169

  • 1. Signaling by ABL oncogenes through cyclin D1.
    Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF.
    Proc Natl Acad Sci U S A; 1995 Oct 10; 92(21):9540-4. PubMed ID: 7568169
    [Abstract] [Full Text] [Related]

  • 2. Rescue of defective mitogenic signaling by D-type cyclins.
    Roussel MF, Theodoras AM, Pagano M, Sherr CJ.
    Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6837-41. PubMed ID: 7624328
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.
    Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON.
    Cell; 1995 Sep 22; 82(6):981-8. PubMed ID: 7553858
    [Abstract] [Full Text] [Related]

  • 5. Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein.
    Hall FL, Williams RT, Wu L, Wu F, Carbonaro-Hall DA, Harper JW, Warburton D.
    Oncogene; 1993 May 22; 8(5):1377-84. PubMed ID: 8479754
    [Abstract] [Full Text] [Related]

  • 6. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.
    Coutts M, Zou X, Calame K.
    Oncogene; 2000 Feb 10; 19(6):801-9. PubMed ID: 10698498
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D1 as a cellular proto-oncogene.
    Bates S, Peters G.
    Semin Cancer Biol; 1995 Apr 10; 6(2):73-82. PubMed ID: 7647309
    [Abstract] [Full Text] [Related]

  • 8. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells.
    Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ.
    Cancer Res; 2002 Jan 15; 62(2):535-41. PubMed ID: 11809706
    [Abstract] [Full Text] [Related]

  • 9. Physical interaction of the retinoblastoma protein with human D cyclins.
    Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA.
    Cell; 1993 May 07; 73(3):499-511. PubMed ID: 8490963
    [Abstract] [Full Text] [Related]

  • 10. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF.
    Mol Reprod Dev; 1997 Jan 07; 46(1):11-8. PubMed ID: 8981358
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.
    Afar DE, Han L, McLaughlin J, Wong S, Dhaka A, Parmar K, Rosenberg N, Witte ON, Colicelli J.
    Immunity; 1997 Jun 07; 6(6):773-82. PubMed ID: 9208849
    [Abstract] [Full Text] [Related]

  • 12. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X, Ma G, Sun T, Liu J, Arlinghaus RB.
    Cancer Res; 2003 Jan 15; 63(2):298-303. PubMed ID: 12543778
    [Abstract] [Full Text] [Related]

  • 13. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
    Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L.
    Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2591-6. PubMed ID: 10688905
    [Abstract] [Full Text] [Related]

  • 14. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
    Uchimaru K, Endo K, Fujinuma H, Zukerberg L, Arnold A, Motokura T.
    Jpn J Cancer Res; 1996 May 14; 87(5):459-65. PubMed ID: 8641982
    [Abstract] [Full Text] [Related]

  • 15. Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection.
    Mahlmann S, McLaughlin J, Afar DE, Mohr R, Kay RJ, Witte ON.
    Leukemia; 1998 Dec 14; 12(12):1858-65. PubMed ID: 9844916
    [Abstract] [Full Text] [Related]

  • 16. Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle.
    Pusch O, Soucek T, Wawra E, Hengstschläger-Ottnad E, Bernaschek G, Hengstschläger M.
    FEBS Lett; 1996 May 06; 385(3):143-8. PubMed ID: 8647239
    [Abstract] [Full Text] [Related]

  • 17. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
    Peterson SR, Gadbois DM, Bradbury EM, Kraemer PM.
    Cancer Res; 1995 Oct 15; 55(20):4651-7. PubMed ID: 7553644
    [Abstract] [Full Text] [Related]

  • 18. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
    Bai RY, Jahn T, Schrem S, Munzert G, Weidner KM, Wang JY, Duyster J.
    Oncogene; 1998 Aug 27; 17(8):941-8. PubMed ID: 9747873
    [Abstract] [Full Text] [Related]

  • 19. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
    Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON.
    Cell; 1991 Jul 12; 66(1):161-71. PubMed ID: 1712671
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK, Langdon WY, Varticovski L.
    Oncogene; 1997 May 08; 14(18):2217-28. PubMed ID: 9174058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.